Retigabine
95%
- Product Code: 124931
CAS:
150812-13-8
| Molecular Weight: | 339.7924 g./mol | Molecular Formula: | C₁₆H₁₉ClFN₃O₂ |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD00912289 | |
| Melting Point: | 168-170℃ | Boiling Point: | 430℃ at 760 mmHg |
| Density: | Storage Condition: | 2-8°C |
Product Description:
Retigabine is primarily used as an anticonvulsant medication for the treatment of epilepsy, specifically for managing partial-onset seizures in adults. It works by enhancing the activity of potassium channels in the brain, which helps stabilize neuronal activity and reduce the occurrence of seizures. This mechanism of action is unique compared to other antiepileptic drugs, making it a valuable option for patients who do not respond adequately to conventional treatments. Retigabine is typically prescribed when other medications have proven ineffective, offering an alternative therapeutic approach for seizure control. However, due to potential side effects such as retinal abnormalities and blue discoloration of the skin and eyes, its use is carefully monitored, and patients are advised to undergo regular eye examinations during treatment.
Product Specification:
| Test | Specification |
|---|---|
| Appearance | White To Reddish Crystalline Powder |
| Purity (%) | 94.5-100 |
| Infrared Spectrum | Conforms To Structure |
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.050 | 10-20 days | ฿670.00 |
+
-
|
| 0.250 | 10-20 days | ฿2,080.00 |
+
-
|
| 1.000 | 10-20 days | ฿5,560.00 |
+
-
|
Retigabine
Retigabine is primarily used as an anticonvulsant medication for the treatment of epilepsy, specifically for managing partial-onset seizures in adults. It works by enhancing the activity of potassium channels in the brain, which helps stabilize neuronal activity and reduce the occurrence of seizures. This mechanism of action is unique compared to other antiepileptic drugs, making it a valuable option for patients who do not respond adequately to conventional treatments. Retigabine is typically prescribed when other medications have proven ineffective, offering an alternative therapeutic approach for seizure control. However, due to potential side effects such as retinal abnormalities and blue discoloration of the skin and eyes, its use is carefully monitored, and patients are advised to undergo regular eye examinations during treatment.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :